DeepImmu
Products & Services
Information
DeepImmu is an end‑to‑end immunopeptidomics discovery service designed to identify and characterize antigens presented on infected cells or tumours, supporting the development of immunotherapies and cancer vaccines. It combines efficient MHC immunopeptide purification, high‑quality LC‑MS/MS acquisition, and AI‑powered data analysis using the DeepNovo® algorithm for confident peptide and neoantigen identification. The service also delivers sequence motif analysis, binding affinity and DeepSelf® immunogenicity predictions, with stringent quality control to ensure reliable, comprehensive results within a streamlined workflow.
